4//SEC Filing
NIFFENEGGER KATHI 4
Accession 0001654954-20-001650
CIK 0001540159other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 6:19 PM ET
Size
5.1 KB
Accession
0001654954-20-001650
Insider Transaction Report
Form 4
NIFFENEGGER KATHI
Chief Financial Officer
Transactions
- Award
Share Option (Right to Buy)
2020-02-12+88,699→ 88,699 totalExercise: $3.16Exp: 2030-02-12→ Common Shares (88,699 underlying)
Footnotes (1)
- [F1]33% vested on 2/12/2020, with a prorata amount of the balance vesting monthly thereafter over the next 36 months until fully vested
Documents
Issuer
Edesa Biotech, Inc.
CIK 0001540159
Entity typeother
Related Parties
1- filerCIK 0001620146
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 6:19 PM ET
- Size
- 5.1 KB